Climate Change Denier on Fossil Fuel Payroll

A leading scientific voice among global warming skeptics received funding from the energy industry while publishing claims that climate change is not driven by human activity.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, U.S. NATIONAL ARCHIVES AND RECORDS ADMINISTRATIONWei-Hock “Willie” Soon, a solar physicist at the Harvard-Smithsonian Center for Astrophysics (CfA), received significant funding from energy companies while publishing studies that suggested solar activity, rather than human-generated greenhouse gasses, was causing dramatic shifts in global climate. Soon, whose work is frequently cited by conservative politicians to support their skepticism of the human role in climate change, accepted more than $1.2 million from fossil-fuel companies over the past decade, according to documents obtained by environmental group Greenpeace under the Freedom of Information Act. During that same period, Soon failed to disclose any the financial conflicts of interests to publishers of his scientific studies, violating journals’ ethical guidelines in several cases, The New York Times reported.

Though the vast majority of climate scientists agree that the Earth’s climate is changing as a result of human activities that increase the amounts of greenhouse gasses into the atmosphere, researchers like Soon foment debate by publishing alternate hypotheses or denials. “The whole doubt-mongering strategy relies on creating the impression of scientific debate,” Naomi Oreskes, a historian of science at Harvard, told the Times. “Willie Soon is playing a role in a certain kind of political theater.”

The CfA announced that it would launch a formal inquiry into Soon’s failure to properly report the energy-industry funding, some of which was also funneled to the CfA itself, according to the newly divulged documents. The investigation will take place even though the institute doesn’t have an official ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies